首页> 外文期刊>Organic process research & development >Process Research and Development of an NK-1 Receptor Antagonist.Enantioseiective Trif luoromethyl Addition to a Ketone in the Preparation of a Chiral Isochroman
【24h】

Process Research and Development of an NK-1 Receptor Antagonist.Enantioseiective Trif luoromethyl Addition to a Ketone in the Preparation of a Chiral Isochroman

机译:NK-1受体拮抗剂的手性异色满体制备过程中酮对映体三氟甲基丙烯酸的制备工艺研究与开发

获取原文
获取原文并翻译 | 示例
       

摘要

CJ-17,493 (4) is a chiral NK-1 receptor antagonist It was first prepared through a diastereoselective crystallization,then through chiral chromatography of a key intermediate,and ultimately via asymmetric synthesis.Multiple routes for the preparation of a key isochroman were demonstrated,and conditions for improved regioselectivity of a Friedel-Crafts acylation were identified.Cesium fluoride was found to be an acceptable initiator for the generation of a nucleophilic trifluoromethyl anion from CF3TMS.A cinchonine-derived catalyst was identified for the enantioseiective addition of the trifluoromethyl group to the ketone,and it was found that the product of the addition would be converted directly to the isochroman by treatment with t-BuOK.A Duff reaction was used for the formylation,and the resulting aldehyde was coupled to amine 5 to afford CJ-17,493 (4).
机译:CJ-17,493(4)是一种手性NK-1受体拮抗剂,它首先是通过非对映选择性结晶制备的,然后通过关键中间体的手性色谱法,最终通过不对称合成制备。证明了制备关键异色满的多种方法,发现氟化铯是从CF3TMS生成亲核三氟甲基阴离子的可接受引发剂。确定了金鸡宁衍生的催化剂,用于将三氟甲基对映体加成酮,发现加成产物可通过用t-BuOK处理直接转化为异色满。使用达夫反应进行甲酰化,将所得醛与胺5偶联,得到CJ-17,493 (4)。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号